COVID-19 and Cardiovascular Disease From Bench to Bedside

被引:255
|
作者
Chung, Mina K. [1 ,2 ,3 ]
Zidar, David A. [3 ,4 ]
Bristow, Michael R. [5 ]
Cameron, Scott J. [1 ,2 ,3 ]
Chan, Timothy [1 ,2 ,3 ]
Harding, Clifford V., III [3 ]
Kwon, Deborah H. [1 ,2 ,3 ]
Singh, Tamanna [1 ,2 ,3 ]
Tilton, John C. [3 ]
Tsai, Emily J. [6 ]
Tucker, Nathan R. [7 ,8 ]
Barnard, John [1 ,2 ]
Loscalzo, Joseph [9 ]
机构
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
[4] Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH USA
[5] Univ Colorado, Anschutz Med Ctr, Aurora, CO USA
[6] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA
[7] Masonic Med Res Inst, Utica, NY USA
[8] Broad Inst Harvard & MIT, Cardiovasc Dis Initiat, Boston, MA USA
[9] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
angiotensin-converting enzyme 2; COVID-19; inflammation; magnetic resonance imaging; thrombosis; ANGIOTENSIN-CONVERTING ENZYME-2; CARDIAC MAGNETIC-RESONANCE; HUMAN CORONAVIRUS NL63; MYOCARDIAL INJURY; SPIKE PROTEIN; VIRUS ENTRY; HYPERTROPHIC CARDIOMYOPATHY; SARS CORONAVIRUS; PROGNOSTIC VALUE; UP-REGULATION;
D O I
10.1161/CIRCRESAHA.121.317997
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential consequences on the cardiovascular health of millions of people who survive infection worldwide. Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the etiologic agent of COVID-19, can infect the heart, vascular tissues, and circulating cells through ACE2 (angiotensin-converting enzyme 2), the host cell receptor for the viral spike protein. Acute cardiac injury is a common extrapulmonary manifestation of COVID-19 with potential chronic consequences. This update provides a review of the clinical manifestations of cardiovascular involvement, potential direct SARS-CoV-2 and indirect immune response mechanisms impacting the cardiovascular system, and implications for the management of patients after recovery from acute COVID-19 infection.
引用
收藏
页码:1214 / 1236
页数:23
相关论文
共 50 条
  • [21] Cardiovascular disease and COVID-19
    Bansal, Manish
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (03) : 247 - 250
  • [22] Covid-19 and cardiovascular disease
    Fulchand, Shivali
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [23] COVID-19 and Cardiovascular Disease
    Clerkin, Kevin J.
    Fried, Justin A.
    Raikhelkar, Jayant
    Sayer, Gabriel
    Griffin, Jan M.
    Masoumi, Amirali
    Jain, Sneha S.
    Burkhoff, Daniel
    Kumaraiah, Deepa
    Rabbani, LeRoy
    Schwartz, Allan
    Uriel, Nir
    CIRCULATION, 2020, 141 (20) : 1648 - 1655
  • [24] COVID-19 and cardiovascular disease
    Guijarro, Carlos
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2020, 32 (06): : 263 - 266
  • [25] COVID-19-associated liver injury: from bedside to bench
    Dongxiao Li
    Xiangming Ding
    Meng Xie
    Dean Tian
    Limin Xia
    Journal of Gastroenterology, 2021, 56 : 218 - 230
  • [26] Cardiovascular disease and cardiovascular outcomes in COVID-19
    Fisher, Miles
    PRACTICAL DIABETES, 2020, 37 (05) : 191 - +
  • [27] COVID-19-associated liver injury: from bedside to bench
    Li, Dongxiao
    Ding, Xiangming
    Xie, Meng
    Tian, Dean
    Xia, Limin
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (03) : 218 - 230
  • [28] Oxidative stress in cardiovascular disease - Successful translation from bench to bedside?
    Schnabel, Renate
    Blankenberg, Stefan
    CIRCULATION, 2007, 116 (12) : 1338 - 1340
  • [29] Emerging Therapies for the Treatment of Atherosclerotic Cardiovascular Disease: From Bench to Bedside
    Kumric, Marko
    Urlic, Hrvoje
    Bozic, Josko
    Vilovic, Marino
    Kurir, Tina Ticinovic
    Glavas, Duska
    Miric, Dino
    Zanchi, Jaksa
    Bradaric-Slujo, Anteo
    Lozo, Mislav
    Borovac, Josip A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [30] Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside
    Villegas, Ana
    Gonzalez, Fernando A.
    Llorente, Leopoldo
    Redondo, Santiago
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 397 - 407